ResearcherChinese PLA General HospitalNo recent work listed

Yi Cai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7773-2064; OpenAlex author ID A5053927760. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

Long Noncoding RNA LINC01503 Silencing Suppresses KLK4 Expression to Impede Pancreatic Cancer Development as miR-1321 Sponge. First author DOI 10.1155/2023/5403344 ↗
CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s40659-017-0149-0 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Baiping An · 1 shared paper, 2023 · strength 0.26
- Paper Long Noncoding RNA LINC01503 Silencing Suppresses KLK4 Expression to Impede Pancreatic Cancer Development as miR-1321 S… DOI 10.1155/2023/5403344 ↗
Yuan Liu · 1 shared paper, 2023 · strength 0.26
- Paper Long Noncoding RNA LINC01503 Silencing Suppresses KLK4 Expression to Impede Pancreatic Cancer Development as miR-1321 S… DOI 10.1155/2023/5403344 ↗
Peng Shen · 1 shared paper, 2018 · strength 0.12
- Paper CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma. DOI 10.1186/s40659-017-0149-0 ↗
Dong Zhang · 1 shared paper, 2018 · strength 0.12
- Paper CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma. DOI 10.1186/s40659-017-0149-0 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.